Cancer Network » Chronic Lymphocytic Leukemia on Feedspot

Cancer Network » Chronic Lymphocytic Leukemia

81 FOLLOWERS

This section features articles on Chronic Lymphocytic Leukemia. Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.

Role of Venetoclax in Patients with High-Risk CLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

European Commission Approves Zanubrutinib for Treatment of CLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

Zanubrutinib Produces Improved Survival Compared with Ibrutinib in Final PFS Analysis for Relapsed/Refractory CLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

Increased Atrial Fibrillation/Stroke Risk Did Not Impact TTD/TTNT Outcomes Associated with Ibrutinib for CLL/SLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

FDA’s ODAC Votes Against Duvelisib for Previously Treated CLL/SLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

Recap: Noninferiority Comparison of Acalabrutinib and Ibrutinib for Previously Treated CLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

FDA Expresses Caution About Increased Risk of Death, Serious AEs Associated With Duvelisib in CLL/SLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

Venetoclax Plus Obinutuzumab Yield PFS Improvement in Untreated CLL, With or Without Ibrutinib

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

Adding Venetoclax to Ibrutinib Improves Rate of MRD Negativity in Previously Untreated CLL

Cancer Network » Chronic Lymphocytic Leukemia

1y ago

Visit website

Introduction and CLL Background

Cancer Network » Chronic Lymphocytic Leukemia

2y ago

Visit website

Follow Cancer Network » Chronic Lymphocytic Leukemia on FeedSpot